Robert Clark
Ophthalmology · Brighton, MINPI 1386648087
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,330 of the $4,675 with a category attached, or 71.2%. 22 manufacturers reported payments, led by Coopervision Inc. at 38.5% of the total. Reporting peaked in 2023 at $2,104 and has fallen 86.8% since, to $278 in 2025.
Across 132 payments — averaging $35.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$2K
- Johnson & Johnson Surgical Vision, Inc.$684
- Alcon$462
- AbbVie$431
- Bausch & Lomb, A Division Of Bausch Health US, LLC$243
- Rxsight Inc$139
- plus $914 from 16 others
What the payments were for
- Travel & lodging$1,33829%
- Food & beverage$3,33071%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 10 | $1,802 |
| Johnson & Johnson Surgical Vision, Inc. | 21 | $684 |
| Alcon | 11 | $462 |
| AbbVie(2 entities) | 30 | $431 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $243 |
| Rxsight Inc | 1 | $139 |
| Novartis | 7 | $124 |
| Glaukos Corporation | 1 | $123 |
| Sun Pharmaceutical Industries Inc. | 6 | $106 |
| Eyevance Pharmaceuticals LLC | 6 | $81 |
| Shire North American Group Inc | 6 | $76 |
| Lensar, Inc. | 1 | $63 |
| Sight Sciences, Inc. | 2 | $54 |
| Kala Pharmaceuticals, Inc. | 3 | $54 |
| NEW World Medical,inc. | 4 | $46 |
| Oyster Point Pharma, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 3 | $42 |
| Apellis Pharmaceuticals, Inc. | 1 | $35 |
| LKC Technologies, Inc. | 1 | $18 |
| Dompe US, Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
| Beaver-visitec International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,675 in reported general payments places this provider in the 85th percentile of 674 ophthalmology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 21 | $17,451 |
| LumiganBimatoprost | 23 | $10,956 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 23 | $7,558 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $3,287 |
| Travoprost | 17 | $3,076 |
| Latanoprost | 98 | $1,917 |
| Brimonidine Tartrate | 11 | $1,892 |
| Timolol Maleate | 24 | $300 |
| Dorzolamide Hcl | 18 | $286 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $431 | $10,95623 claims |
| AlconSimbrinza | $462 | $7,55823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in Brighton
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
- Yannis PaulusAnn Arbor$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.